Evidence map›Paper›PMID 40283634›Full record

ArticleJournal of clinical medicine2025

Leucine-Rich Alpha-2 Glycoprotein 1 as a Biomarker for Evaluation of Inflammatory Bowel Disease Activity in Children.

Betül Aksoy, Yeliz Çağan Appak, Murat Akşit, Serenay Çetinoğlu, Sinem Kahveci, Şenay Onbaşı Karabağ, Selen Güler, İlksen Demir, İnanç Karakoyun, Maşallah Baran

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Betül AksoyDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Izmir, Turkey.ORCID 0000-0002-7657-8007
Yeliz Çağan AppakDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Izmir, Turkey.
Murat AkşitDepartment of Medical Biochemistry, Tepecik Training and Research Hospital, 35020 Izmir, Turkey.
Serenay ÇetinoğluDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Izmir, Turkey.ORCID 0000-0003-3774-3994
Sinem KahveciDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Izmir City Hospital, 35540 Izmir, Turkey.
Şenay Onbaşı KarabağDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Izmir City Hospital, 35540 Izmir, Turkey.
Selen GülerDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Izmir, Turkey.
İlksen DemirDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Izmir, Turkey.
İnanç KarakoyunDepartment of Medical Biochemistry, Izmir City Hospital, 35540 Izmir, Turkey.
Maşallah BaranDepartment of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Izmir Katip Celebi University, Izmir City Hospital, 35540 Izmir, Turkey.ORCID 0000-0003-3827-2039

Funding

Turkish Society for Pediatric Gastroenterology Hepatology and Nutrition 2
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerinflammatory bowel diseaseleucine-rich alpha-2 glycoprotein 1

Identifiers

PMID40283634
PMCPMC12028201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.